| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 257.060 | 239.210 | 226.268 | 172.204 | 151.750 | 102.754 | 111.790 | 125.330 | 113.835 | 160.546 |
| Total Income - EUR | 264.874 | 245.460 | 226.949 | 172.755 | 154.366 | 102.757 | 170.740 | 125.333 | 113.835 | 160.546 |
| Total Expenses - EUR | 258.479 | 240.588 | 220.747 | 168.837 | 153.288 | 114.063 | 149.942 | 122.913 | 110.564 | 155.515 |
| Gross Profit/Loss - EUR | 6.395 | 4.872 | 6.202 | 3.919 | 1.077 | -11.306 | 20.798 | 2.421 | 3.271 | 5.031 |
| Net Profit/Loss - EUR | 5.126 | 4.143 | 3.733 | 3.183 | 915 | -11.370 | 15.226 | 2.033 | 3.079 | 4.337 |
| Employees | 22 | 20 | 18 | 11 | 10 | 11 | 11 | 10 | 9 | 10 |
Check the financial reports for the company - Sucidava S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 318.349 | 280.971 | 232.723 | 273.307 | 285.217 | 273.313 | 253.707 | 240.256 | 234.404 | 237.524 |
| Current Assets | 55.177 | 51.062 | 66.202 | 47.507 | 43.809 | 35.159 | 38.403 | 18.186 | 23.090 | 32.093 |
| Inventories | 8.551 | 7.962 | 7.864 | 7.845 | 7.787 | 8.795 | 7.039 | 7.061 | 9.366 | 7.001 |
| Receivables | 21.781 | 14.151 | 22.275 | 22.681 | 13.712 | 9.303 | 12.463 | 9.124 | 12.847 | 20.673 |
| Cash | 24.846 | 28.949 | 36.063 | 16.980 | 22.310 | 17.061 | 18.901 | 2.000 | 876 | 4.420 |
| Shareholders Funds | 325.905 | 295.322 | 273.153 | 269.623 | 264.493 | 248.108 | 257.833 | 253.188 | 251.444 | 253.597 |
| Social Capital | 68.127 | 67.432 | 66.291 | 65.075 | 63.814 | 62.605 | 61.216 | 61.406 | 61.220 | 60.878 |
| Debts | 47.621 | 36.711 | 25.773 | 51.642 | 68.281 | 63.426 | 34.278 | 5.254 | 6.050 | 16.020 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Sucidava S.a.